MARK SPATZ: Open Payments
NPI 1083803068 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,356 in 120 payments from 20 companies in 2025. Trend: 2023 $2,030 · 2024 $2,849 · 2025 $3,356
Food & beverage: $3,276Education: $80
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 22 | $773 |
| ABBVIE INC. | 22 | $728 |
| Galderma Laboratories, L.P. | 16 | $253 |
| Amgen Inc. | 8 | $236 |
| Janssen Biotech, Inc. | 5 | $226 |
| GENZYME CORPORATION | 8 | $199 |
| UCB, Inc. | 11 | $184 |
| LEO Pharma Inc. | 7 | $183 |
| Lilly USA, LLC | 2 | $108 |
| PFIZER INC. | 5 | $90 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, NEMLUVIO, OTEZLA, TREMFYA, Bimzelx, ADBRY.
Industry payments across GA — which companies pay providers there.
